Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy

Scandinavian Journal of Public Health

Volumn 30, Issue 1, 2002, Pages 12-19

  Hedblad, Bo ^a   Manjer, Jonas ^a   Engström, Gunnar ^a   Janzon, Lars ^a   Berglund, Göran ^a   Merlo, Juan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cancer; cardiovascular; mortality; population; postmenopausal HRT

Indexed keywords

ADULT; ARTICLE; BREAST TUMOR; COHORT ANALYSIS; ENDOMETRIUM TUMOR; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MIDDLE AGED; MORTALITY; RISK FACTOR; SWEDEN; UTILIZATION REVIEW; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLIMACTERIUM; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FOLLOW UP; HORMONE SUBSTITUTION; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MEDICAL ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; STATISTICAL ANALYSIS; URBAN POPULATION;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SWEDEN;

ESTROGEN;

EID: 84993741923     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/14034948020300010601     Document Type: Article

References (40)

1. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-1037.
2. Grodstein F., Stampfer M.J. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38: 199-210.
3. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605-613.
4. Colditz G.A., Hankinson S.E., Hunter D.J., Willett W.C., Manson J.E., Stampfer M.J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-1593.
5. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 1997; 350: 1047-1059.
6. Bergkvist L., Adami H.O., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen-progestin replacement. N Engl J Med 1989; 321: 293-7.
7. Risch H.A., Howe G.R. Menopausal hormone usage and breast cancer in Saskatchewan: A Recode-Linkage Cohort Study. Am J Epidemiol 1994; 139: 670-683.
8. Persson I., Adami H.O., Bergkvist L., Lindgren A., Pettersson B., Hoover R., et al. Risk of endometrial cancer after treatment with oestrogen alone or in conjunction with progestogens: results of a prospective study. Br Med J 1989; 298: 147-151.
9. Sourander L., Rajala T., Räihä I., Maäkinen J., Erkkola R., Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet 1998; 352: 1965-1969.
10. Grady D., Wenger N.K., Herrington D., Khan S., Furberg C., Hunninghake D., et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000; 132: 689-696.
11. Wilson P.W., Garrison R.J., Castelli W.P. Postmenopausal estrogen use, cigarette smoking, cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985; 313: 1038-1043.
12. Henderson B.E., Paganini-Hill A., Ross R.K. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151: 75-78.
13. Petitti D.B., Perman J.A., Sidney S. Noncontraceptive estrogens and mortality; long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol 1987; 70: 289-293.
14. Folsom A.R., Mink P.J., Sellers T.A., Hong C.P., Zheng W., Potter J.D. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995; 85: 1128-1132.
15. Criqui M.H., Suarez L., Barrett-Connor E., McPhillips J., Wingard D.L., Garland C. Postmenopausal estrogen use and mortality: results from a prospective study in a defi ned, homogeneous community. Am J Epidemiol 1988; 128: 606-614.
16. Ettinger B., Friedman G.D., Bush T., Quesenberry C.P. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996; 87: 6-12.
17. Grodstein F., Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Joffe M., et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336: 1769-1775.
18. Vandenbroucke J.P. Postmenopausal oestrogen and cardioprotection. Lancet 1991; 337: 833-4.
19. Posthuma W.F., Westendorp R.G., Vandenbroucke J.P. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? Br Med J 1994; 308: 1268-9.
20. Sturgeon S.R., Schairer C., Brinton L.A., Pearson T., Hoover R.N. Evidence of a healthy estrogen user survivor effect. Epidemiology 1995; 6: 227-231.
21. Trell E. Community-based preventive medical department for individual risk factors assessment and intervention in an urban area. Prev Med 1983; 12: 397-402.
22. Berglund G., Eriksson K.-F., Israelsson B., Kjellström T., Lindgärde F., Mattiasson I., et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 1996; 239: 489-497.
23. Swedish National Bureau of Statistics. Swedish socio-economic classifi cation. Stockholm: Swedish National Bureau of Statistics, Stockholm, Sweden 1995 (in Swedish).
24. National Board on Health and Welfare. Värdering av diagnoskvaliteten för akut hjärtinfarkt i tre svenska län. Artikelnr 1997-84-8, Stockholm, Sweden 1997 (in Swedish).
25. Causes of death 1995. Stockholm, Sweden: National Board of Health and Welfare. Centre of Epidemiology, 1997 (ISBN 91-7201-188-2).
26. Cancer incidence in Sweden 1995. The Swedish Cancer Registry. Stockholm, Sweden: Centre of Epidemiology, National Board of Health and Welfare, 1998 (ISBN 91-7201-238-2).
27. Tydén P., Hansen O., Janzon L. Intra-urban variations in incidence and mortality in myocardial infarction. A study from the myocardial infarction register in the city of Malmö, Sweden. Eur Heart J 1998; 19: 1795-1801.
28. Classification of causes of death in Swedish statistics. Reports on Statistical Co-ordination 1990:3. Stockholm, Sweden: Statistics Sweden, 1990 (ISBN 0082-0029).
29. Norusis M.J. SPSS/PC+ Statistics 4.0 for the IBM PC/XT/AT and PS/2. Chicago: SPSS, 1990.
30. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
31. Cox D.R. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
32. Merlo J., Janzon L., Berglund G., Hovelius B., Hedblad B., Wirfält E., et al. Self-administered questionnaire is a simple and valid method compared to a personal diary for assessment of current exposure to hormone therapy-an analysis of 16,060 women. Am J of Epidemiol 2000; 152: 788-792.
33. Marmot M.G., McDowall M.E. Mortality decline and widening social inequalities. Lancet 1986; ii: 274-6.
34. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273: 199-208.
35. Guetta V., Cannon I.I.I. R.O. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996; 93: 1928-1937.
36. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998; 19: 61-109.
37. Garne J.P., Aspegren K., Möller T. Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1961-1970. Acta Oncol 1990; 29: 125-8.
38. Garne J.P., Aspegren K., Möller T. Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1971-1991. Acta Oncol 1995; 34: 153-6.
39. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115: 455-6.
40. Petitti D.B. Coronary heart disease and oestrogen replacement therapy: can compliance bias explain the results of observational studies. Ann Epidemiol 1994; 4: 115-118.